CRSP — CRISPR THERAPEUTICS AG

Ownership history in Integrated Advisors Network LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Integrated Advisors Network LLC reported a position in CRISPR THERAPEUTICS AG (CRSP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q1)
Avg. % of fund
0.02%
First filed
2023 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 3,261 -2,169 -39.9% 0.01% $211K $64.81
2024 Q2 REDUCED 5,430 -3,378 -38.4% 0.02% $293K $54.01
2024 Q1 ADDED 8,808 +1,105 +14.3% 0.03% $600K $68.16
2023 Q4 ADDED 7,703 +500 +6.9% 0.03% $482K $62.60
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CRSP price (monthly, adj. close)

Other funds also holding CRSP

As of 2025 Q4 — sorted by position size

GSK plc 21.14% SR ONE CAPITAL MANAGEMENT, LP 3Y 15.14% Versant Venture Management, LLC 3Y 7Y 5.17% ARK Investment Management LLC 3Y 7Y 3.66% EcoR1 Capital, LLC 3Y 7Y 3.31% NEA Management Company, LLC 3Y 7Y 2.83% Green Alpha Advisors, LLC 3Y 2.68% Stonepine Capital Management, LLC 3Y 7Y 1.91% IQ EQ FUND MANAGEMENT (IRELAND) Ltd 3Y 7Y 1.41% Orbis Allan Gray Ltd 3Y 7Y 1.31%
← Back to Integrated Advisors Network LLC Holdings